Prime Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.59	0	0	0	5.21
Gross Profit	0.59	0	0	0	5.21
Selling, General & Admin	45.39	43.39	29.82	13.92	3.16
Research & Development	154.8	147.91	86.73	70.55	2.98
Other Operating Expenses	13.5	13.5	0	0	0
Operating Expenses	213.69	204.79	116.54	84.47	6.14
Operating Income	-213.1	-204.79	-116.54	-84.47	-0.93
Other Expense / Income	-8.66	-6.38	6.23	81.38	0.61
Pretax Income	-204.44	-198.41	-122.77	-165.85	-1.54
Income Tax	0.06	-0.28	-0.95	-0.49	1.87
Net Income	-204.5	-198.13	-121.82	-165.37	-3.41
Preferred Dividends	0	0	20.19	18.75	1.65
Net Income Common	-204.5	-198.13	-142.01	-184.12	-5.06
Shares Outstanding (Basic)	104	91	34	13	3
Shares Outstanding (Diluted)	104	91	34	13	3
Shares Change	17.29%	168.42%	161.23%	391.47%	-
EPS (Basic)	-2.18	-2.18	-4.19	-14.19	-1.91
EPS (Diluted)	-2.18	-2.18	-4.19	-14.19	-1.91
Free Cash Flow	-200.61	-174.14	-147.92	-38.23	-6.18
Free Cash Flow Per Share	-1.92	-1.91	-4.37	-2.95	-2.34
Gross Margin	100.00%	-	-	-	100.00%
Operating Margin	-36057.53%	-	-	-	-17.89%
Profit Margin	-34601.86%	-	-	-	-97.02%
Free Cash Flow Margin	-33943.65%	-	-	-	-118.68%
EBITDA	-186.22	-180.97	-110.76	-160.99	-1.5
EBITDA Margin	-31509.14%	-	-	-	-28.79%
Depreciation & Amortization	18.22	17.44	12.01	4.86	0.04
EBIT	-204.44	-198.41	-122.77	-165.85	-1.54
EBIT Margin	-34592.22%	-	-	-	-29.62%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).